Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 5, 2012. The report details a specific share repurchase transaction executed under authority granted by shareholders at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 690,800 Ordinary Shares of 25 pence each.
- Purchase Date: December 5, 2012.
- Price Range: Highest price paid was 1,356.0 pence per share; lowest price paid was 1,339.5 pence per share.
- Treasury Holdings (Settled): 490,140,427 shares (9.08% of total issued share capital).
- Treasury Holdings (Including Unsettled): 490,831,227 shares (10.00% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,908,398,029 shares.
Material Changes
The primary material change reported is the increase in the Company's treasury share holdings following the purchase of 690,800 shares. This transaction increased the proportion of treasury shares representing total voting rights to exactly 10.00% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules. The text explicitly states it does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (490,831,227) against the 10.00% voting rights threshold.
- Confirm the number of shares in issue (4,908,398,029) for calculating individual shareholder notification thresholds under Disclosure and Transparency Rules.
- Review the price paid per share (1,339.5 to 1,356.0 pence) against market prices on December 5, 2012.
- Note that this filing does not contain financial performance data; refer to Form 20-F for annual results.